| Dr Denis G Foster, MD | |
|
709 W Orchard Dr, Suite 4, Bellingham, WA 98225-1766 | |
| (360) 318-8800 | |
| (360) 318-1085 |
| Full Name | Dr Denis G Foster |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 709 W Orchard Dr, Bellingham, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093755100 | NPI | - | NPPES |
| 03806 | Other | WA | REGENCE BLUESHIELD |
| 0130088 | Other | WA | LABOR & INDUSTRIES (REG) |
| 8925066 | Other | WA | LABOR & INDUSTRIES (CV) |
| 423898029 | Other | WA | GROUP HEALTH COOPERATIVE |
| 1501907 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD00017015 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Denis G Foster, MD 709 W Orchard Dr, Suite 4, Bellingham, WA 98225-1766 Ph: (360) 318-8800 | Dr Denis G Foster, MD 709 W Orchard Dr, Suite 4, Bellingham, WA 98225-1766 Ph: (360) 318-8800 |
News Archive
Which antiplatelet medication is best after a coronary stent? The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines whether prescribing heart medication based on a patient's CYP2C19 genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo percutaneous coronary intervention (PCI), commonly called angioplasty.
Phase Forward Incorporated, a leading provider of data management solutions for clinical trials and drug safety, announced that the United States Department of Justice has closed its investigation of the proposed acquisition of Phase Forward by Oracle Corporation, and that the waiting period under the Hard-Scott-Rodino Antitrust Improvements Act of 1976 regarding the Merger has been terminated.
Private Medicare Advantage and prescription drug plan options are fewer for 2011, and some Nashville-area seniors may face higher out-of-pocket expenses for the private insurance.
The Ministry of Health in China has confirmed the country's 19th case of human infection with the H5N1 avian influenza virus.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.
› Verified 6 days ago
Dr. Kellie L. Jacobs, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Orchard Pl, Bellingham, WA 98225 Phone: 360-671-3900 Fax: 360-647-0882 | |
Lora C Sherman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4455 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-671-3225 Fax: 360-671-0000 | |
Dr. Jessica Ruth Hanford, M.D., MPH Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3015 Squalicum Parkway, Suite 220, Bellingham, WA 98225 Phone: 360-676-1693 Fax: 360-676-5458 | |
Elijah Kamermans, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2608 Kwina Rd, Bellingham, WA 98226 Phone: 360-312-2000 | |
Dr. Warren Billings Howe, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 516 High St, Wwu Student Health (ms-9132), Bellingham, WA 98225 Phone: 360-650-3400 Fax: 360-650-3883 | |
Gabrielle Worzella, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 Unity St, Bellingham, WA 98225 Phone: 360-676-6177 Fax: 360-671-3574 |